Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,888 | -9,457 | -11,998 | -44,568 | -31,869 |
| Depreciation Amortization | 255 | 174 | 280 | 1,052 | 771 |
| Accounts payable and accrued liabilities | -737 | -891 | 1,329 | -469 | 812 |
| Other Working Capital | -820 | -1,329 | 477 | -2,053 | -1,563 |
| Other Operating Activity | 1,447 | 1,382 | -249 | 4,816 | 2,318 |
| Operating Cash Flow | $-14,743 | $-10,121 | $-10,161 | $-41,222 | $-29,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -37 | -26 | -397 | -364 |
| Sale Of Investment | N/A | N/A | N/A | 4,385 | 4,385 |
| Other Investing Activity | 44 | 44 | 0 | 0 | 0 |
| Investing Cash Flow | $-1 | $7 | $-26 | $3,988 | $4,021 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -10 | -202 | -143 |
| Common Stock Issued | 38 | 27 | 5,599 | 27,145 | 471 |
| Other Financing Activity | 34,531 | 34,531 | 0 | 0 | -245 |
| Financing Cash Flow | $34,569 | $34,558 | $5,589 | $26,943 | $83 |
| Exchange Rate Effect | N/A | N/A | -37 | 33 | 5 |
| Beginning Cash Position | 3,244 | 3,244 | 63,512 | 73,770 | 73,770 |
| End Cash Position | 23,069 | 27,688 | 58,877 | 63,512 | 48,348 |
| Net Cash Flow | $19,825 | $24,444 | $-4,635 | $-10,258 | $-25,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,743 | -10,121 | -10,161 | -41,222 | -29,531 |
| Capital Expenditure | -45 | -37 | -26 | -397 | -364 |
| Free Cash Flow | -14,788 | -10,158 | -10,187 | -41,619 | -29,895 |